Autologous Keratinocyte Suspension Versus Adipose-Derived Stem Cell-Keratinocyte Suspension for Post-Burn Raw Area
Condition(s):Burn With Full-Thickness Skin LossLast Updated:May 12, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Burn With Full-Thickness Skin LossLast Updated:May 12, 2020Unknown status
Condition(s):Burns; Pain, Burning; AnxietyLast Updated:October 10, 2023Not yet recruiting
Condition(s):BurnsLast Updated:September 11, 2017Withdrawn
Condition(s):BurnsLast Updated:January 12, 2022Completed
Condition(s):BurnsLast Updated:September 1, 2020Completed
Condition(s):Burn Any Degree Involving 20-29 Percent of Body Surface; Burn Any Degree Involving 30-39 Percent of Body Surface; Burn Any Degree Involving 40-49 Percent of Body Surface; Burn Any Degree Involving 50-59 Percent of Body Surface; Burn Any Degree Involving 60-65 Percent of Body Surface; Fluid ResuscitationLast Updated:February 18, 2019Terminated
Condition(s):BurnsLast Updated:February 15, 2023Not yet recruiting
Condition(s):Burns; Self Efficacy; Burn Second Degree; Burns Third Degree; Quality of Life; Adherence, Treatment; Burn InjuryLast Updated:March 5, 2024Not yet recruiting
Condition(s):Burn Contracture of SkinLast Updated:November 16, 2022Recruiting
Condition(s):BurnLast Updated:July 26, 2012Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.